S1PR1 and heart disorder: Although previous studies and our present report support a potential application of S1P analogue in heart diseases, we should take cautions on its side effect on heart rate.30 Some reports showed that fingolimod reduced heart rate (bradycardia) in rats.30 Gergely et al31 showed that an S1pr1 selective ligand results in transient bradycardia in humans.